Table of Content

1 IDH1 Antibody Market Overview
1.1 IDH1 Antibody Product Overview
1.2 IDH1 Antibody Market Segment by Type
1.2.1 Monoclonal
1.2.2 Polyclonal
1.3 Global IDH1 Antibody Market Size by Type
1.3.1 Global IDH1 Antibody Market Size Overview by Type (2018-2033)
1.3.2 Global IDH1 Antibody Historic Market Size Review by Type (2018-2023)
1.3.3 Global IDH1 Antibody Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America IDH1 Antibody Sales Breakdown by Type (2018-2023)
1.4.2 Europe IDH1 Antibody Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific IDH1 Antibody Sales Breakdown by Type (2018-2023)
1.4.4 Latin America IDH1 Antibody Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa IDH1 Antibody Sales Breakdown by Type (2018-2023)
2 Global IDH1 Antibody Market Competition by Company
2.1 Global Top Players by IDH1 Antibody Sales (2018-2023)
2.2 Global Top Players by IDH1 Antibody Revenue (2018-2023)
2.3 Global Top Players by IDH1 Antibody Price (2018-2023)
2.4 Global Top Manufacturers IDH1 Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 IDH1 Antibody Market Competitive Situation and Trends
2.5.1 IDH1 Antibody Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by IDH1 Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in IDH1 Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into IDH1 Antibody Market
2.8 Key Manufacturers IDH1 Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 IDH1 Antibody Status and Outlook by Region
3.1 Global IDH1 Antibody Market Size and CAGR by Region: 2018 VS 2022 VS 2033
3.2 Global IDH1 Antibody Historic Market Size by Region
3.2.1 Global IDH1 Antibody Sales in Volume by Region (2018-2023)
3.2.2 Global IDH1 Antibody Sales in Value by Region (2018-2023)
3.2.3 Global IDH1 Antibody Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global IDH1 Antibody Forecasted Market Size by Region
3.3.1 Global IDH1 Antibody Sales in Volume by Region (2024-2033)
3.3.2 Global IDH1 Antibody Sales in Value by Region (2024-2033)
3.3.3 Global IDH1 Antibody Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global IDH1 Antibody by Application
4.1 IDH1 Antibody Market Segment by Application
4.1.1 Immunochemistry (IHC)
4.1.2 Immunofluorescence (IF)
4.1.3 Immunoprecipitation (IP)
4.1.4 Western Blot (WB)
4.1.5 ELISA
4.1.6 Others
4.2 Global IDH1 Antibody Market Size by Application
4.2.1 Global IDH1 Antibody Market Size Overview by Application (2018-2033)
4.2.2 Global IDH1 Antibody Historic Market Size Review by Application (2018-2023)
4.2.3 Global IDH1 Antibody Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America IDH1 Antibody Sales Breakdown by Application (2018-2023)
4.3.2 Europe IDH1 Antibody Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific IDH1 Antibody Sales Breakdown by Application (2018-2023)
4.3.4 Latin America IDH1 Antibody Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa IDH1 Antibody Sales Breakdown by Application (2018-2023)
5 North America IDH1 Antibody by Country
5.1 North America IDH1 Antibody Historic Market Size by Country
5.1.1 North America IDH1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
5.1.2 North America IDH1 Antibody Sales in Volume by Country (2018-2023)
5.1.3 North America IDH1 Antibody Sales in Value by Country (2018-2023)
5.2 North America IDH1 Antibody Forecasted Market Size by Country
5.2.1 North America IDH1 Antibody Sales in Volume by Country (2024-2033)
5.2.2 North America IDH1 Antibody Sales in Value by Country (2024-2033)
6 Europe IDH1 Antibody by Country
6.1 Europe IDH1 Antibody Historic Market Size by Country
6.1.1 Europe IDH1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
6.1.2 Europe IDH1 Antibody Sales in Volume by Country (2018-2023)
6.1.3 Europe IDH1 Antibody Sales in Value by Country (2018-2023)
6.2 Europe IDH1 Antibody Forecasted Market Size by Country
6.2.1 Europe IDH1 Antibody Sales in Volume by Country (2024-2033)
6.2.2 Europe IDH1 Antibody Sales in Value by Country (2024-2033)
7 Asia-Pacific IDH1 Antibody by Region
7.1 Asia-Pacific IDH1 Antibody Historic Market Size by Region
7.1.1 Asia-Pacific IDH1 Antibody Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033
7.1.2 Asia-Pacific IDH1 Antibody Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific IDH1 Antibody Sales in Value by Region (2018-2023)
7.2 Asia-Pacific IDH1 Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific IDH1 Antibody Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific IDH1 Antibody Sales in Value by Region (2024-2033)
8 Latin America IDH1 Antibody by Country
8.1 Latin America IDH1 Antibody Historic Market Size by Country
8.1.1 Latin America IDH1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
8.1.2 Latin America IDH1 Antibody Sales in Volume by Country (2018-2023)
8.1.3 Latin America IDH1 Antibody Sales in Value by Country (2018-2023)
8.2 Latin America IDH1 Antibody Forecasted Market Size by Country
8.2.1 Latin America IDH1 Antibody Sales in Volume by Country (2024-2033)
8.2.2 Latin America IDH1 Antibody Sales in Value by Country (2024-2033)
9 Middle East and Africa IDH1 Antibody by Country
9.1 Middle East and Africa IDH1 Antibody Historic Market Size by Country
9.1.1 Middle East and Africa IDH1 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
9.1.2 Middle East and Africa IDH1 Antibody Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa IDH1 Antibody Sales in Value by Country (2018-2023)
9.2 Middle East and Africa IDH1 Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa IDH1 Antibody Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa IDH1 Antibody Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck IDH1 Antibody Products Offered
10.1.5 Merck Recent Development
10.2 GeneTex
10.2.1 GeneTex Company Information
10.2.2 GeneTex Introduction and Business Overview
10.2.3 GeneTex IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GeneTex IDH1 Antibody Products Offered
10.2.5 GeneTex Recent Development
10.3 Abcam
10.3.1 Abcam Company Information
10.3.2 Abcam Introduction and Business Overview
10.3.3 Abcam IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abcam IDH1 Antibody Products Offered
10.3.5 Abcam Recent Development
10.4 BosterBio
10.4.1 BosterBio Company Information
10.4.2 BosterBio Introduction and Business Overview
10.4.3 BosterBio IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.4.4 BosterBio IDH1 Antibody Products Offered
10.4.5 BosterBio Recent Development
10.5 Proteintech Group
10.5.1 Proteintech Group Company Information
10.5.2 Proteintech Group Introduction and Business Overview
10.5.3 Proteintech Group IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Proteintech Group IDH1 Antibody Products Offered
10.5.5 Proteintech Group Recent Development
10.6 Abnova Corporation
10.6.1 Abnova Corporation Company Information
10.6.2 Abnova Corporation Introduction and Business Overview
10.6.3 Abnova Corporation IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Abnova Corporation IDH1 Antibody Products Offered
10.6.5 Abnova Corporation Recent Development
10.7 Novus Biologicals
10.7.1 Novus Biologicals Company Information
10.7.2 Novus Biologicals Introduction and Business Overview
10.7.3 Novus Biologicals IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Novus Biologicals IDH1 Antibody Products Offered
10.7.5 Novus Biologicals Recent Development
10.8 NSJ Bioreagents
10.8.1 NSJ Bioreagents Company Information
10.8.2 NSJ Bioreagents Introduction and Business Overview
10.8.3 NSJ Bioreagents IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.8.4 NSJ Bioreagents IDH1 Antibody Products Offered
10.8.5 NSJ Bioreagents Recent Development
10.9 LifeSpan BioSciences
10.9.1 LifeSpan BioSciences Company Information
10.9.2 LifeSpan BioSciences Introduction and Business Overview
10.9.3 LifeSpan BioSciences IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.9.4 LifeSpan BioSciences IDH1 Antibody Products Offered
10.9.5 LifeSpan BioSciences Recent Development
10.10 Abeomics
10.10.1 Abeomics Company Information
10.10.2 Abeomics Introduction and Business Overview
10.10.3 Abeomics IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Abeomics IDH1 Antibody Products Offered
10.10.5 Abeomics Recent Development
10.11 ProSci
10.11.1 ProSci Company Information
10.11.2 ProSci Introduction and Business Overview
10.11.3 ProSci IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.11.4 ProSci IDH1 Antibody Products Offered
10.11.5 ProSci Recent Development
10.12 QED Bioscience
10.12.1 QED Bioscience Company Information
10.12.2 QED Bioscience Introduction and Business Overview
10.12.3 QED Bioscience IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.12.4 QED Bioscience IDH1 Antibody Products Offered
10.12.5 QED Bioscience Recent Development
10.13 Cell Signaling Technology
10.13.1 Cell Signaling Technology Company Information
10.13.2 Cell Signaling Technology Introduction and Business Overview
10.13.3 Cell Signaling Technology IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Cell Signaling Technology IDH1 Antibody Products Offered
10.13.5 Cell Signaling Technology Recent Development
10.14 RayBiotech
10.14.1 RayBiotech Company Information
10.14.2 RayBiotech Introduction and Business Overview
10.14.3 RayBiotech IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.14.4 RayBiotech IDH1 Antibody Products Offered
10.14.5 RayBiotech Recent Development
10.15 EpiGentek
10.15.1 EpiGentek Company Information
10.15.2 EpiGentek Introduction and Business Overview
10.15.3 EpiGentek IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.15.4 EpiGentek IDH1 Antibody Products Offered
10.15.5 EpiGentek Recent Development
10.16 Enzo Life Sciences
10.16.1 Enzo Life Sciences Company Information
10.16.2 Enzo Life Sciences Introduction and Business Overview
10.16.3 Enzo Life Sciences IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Enzo Life Sciences IDH1 Antibody Products Offered
10.16.5 Enzo Life Sciences Recent Development
10.17 OriGene Technologies
10.17.1 OriGene Technologies Company Information
10.17.2 OriGene Technologies Introduction and Business Overview
10.17.3 OriGene Technologies IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.17.4 OriGene Technologies IDH1 Antibody Products Offered
10.17.5 OriGene Technologies Recent Development
10.18 Jingjie PTM BioLab
10.18.1 Jingjie PTM BioLab Company Information
10.18.2 Jingjie PTM BioLab Introduction and Business Overview
10.18.3 Jingjie PTM BioLab IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Jingjie PTM BioLab IDH1 Antibody Products Offered
10.18.5 Jingjie PTM BioLab Recent Development
10.19 Beijing Solarbio
10.19.1 Beijing Solarbio Company Information
10.19.2 Beijing Solarbio Introduction and Business Overview
10.19.3 Beijing Solarbio IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Beijing Solarbio IDH1 Antibody Products Offered
10.19.5 Beijing Solarbio Recent Development
10.20 Biobyt
10.20.1 Biobyt Company Information
10.20.2 Biobyt Introduction and Business Overview
10.20.3 Biobyt IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Biobyt IDH1 Antibody Products Offered
10.20.5 Biobyt Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 IDH1 Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 IDH1 Antibody Industrial Chain Analysis
11.4 IDH1 Antibody Market Dynamics
11.4.1 IDH1 Antibody Industry Trends
11.4.2 IDH1 Antibody Market Drivers
11.4.3 IDH1 Antibody Market Challenges
11.4.4 IDH1 Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 IDH1 Antibody Distributors
12.3 IDH1 Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monoclonal
Table 2. Major Company of Polyclonal
Table 3. Global IDH1 Antibody Sales by Type 2018 VS 2022 VS 2033 (US$ Million)
Table 4. Global IDH1 Antibody Sales by Type (2018-2023) & (ml)
Table 5. Global IDH1 Antibody Sales Market Share in Volume by Type (2018-2023)
Table 6. Global IDH1 Antibody Sales by Type (2018-2023) & (US& Million)
Table 7. Global IDH1 Antibody Market Share in Value by Type (2018-2023)
Table 8. Global IDH1 Antibody Price by Type (2018-2023) & (US$/ml)
Table 9. Global IDH1 Antibody Sales by Type (2024-2033) & (ml)
Table 10. Global IDH1 Antibody Sales Market Share in Volume by Type (2024-2033)
Table 11. Global IDH1 Antibody Sales by Type (2024-2033) & (US$ Million)
Table 12. Global IDH1 Antibody Sales Market Share in Value by Type (2024-2033)
Table 13. Global IDH1 Antibody Price by Type (2024-2033) & (US$/ml)
Table 14. North America IDH1 Antibody Sales by Type (2018-2023) & (ml)
Table 15. North America IDH1 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe IDH1 Antibody Sales (ml) by Type (2018-2023)
Table 17. Europe IDH1 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific IDH1 Antibody Sales (ml) by Type (2018-2023)
Table 19. Asia-Pacific IDH1 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America IDH1 Antibody Sales (ml) by Type (2018-2023)
Table 21. Latin America IDH1 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa IDH1 Antibody Sales (ml) by Type (2018-2023)
Table 23. Middle East and Africa IDH1 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 24. Global IDH1 Antibody Sales by Company (2018-2023) & (ml)
Table 25. Global IDH1 Antibody Sales Share by Company (2018-2023)
Table 26. Global IDH1 Antibody Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global IDH1 Antibody Revenue Share by Company (2018-2023)
Table 28. Global Market IDH1 Antibody Price by Company (2018-2023) & (US$/ml)
Table 29. Global IDH1 Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global IDH1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in IDH1 Antibody as of 2022)
Table 32. Date of Key Manufacturers Enter into IDH1 Antibody Market
Table 33. Key Manufacturers IDH1 Antibody Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global IDH1 Antibody Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2033
Table 36. Global IDH1 Antibody Sales by Region (2018-2023) & (ml)
Table 37. Global IDH1 Antibody Sales Market Share in Volume by Region (2018-2023)
Table 38. Global IDH1 Antibody Sales by Region (2018-2023) & (US$ Million)
Table 39. Global IDH1 Antibody Sales Market Share in Value by Region (2018-2023)
Table 40. Global IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 41. Global IDH1 Antibody Sales by Region (2024-2033) & (ml)
Table 42. Global IDH1 Antibody Sales Market Share in Volume by Region (2024-2033)
Table 43. Global IDH1 Antibody Sales by Region (2024-2033) & (US$ Million)
Table 44. Global IDH1 Antibody Sales Market Share in Value by Region (2024-2033)
Table 45. Global IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2024-2033)
Table 46. Global IDH1 Antibody Sales by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 47. Global IDH1 Antibody Sales by Application (2018-2023) & (ml)
Table 48. Global IDH1 Antibody Sales Market Share in Volume by Application (2018-2023)
Table 49. Global IDH1 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 50. Global IDH1 Antibody Sales Market Share in Value by Application (2018-2023)
Table 51. Global IDH1 Antibody Price by Application (2018-2023) & (US$/ml)
Table 52. Global IDH1 Antibody Sales by Application (2024-2033) & (ml)
Table 53. Global IDH1 Antibody Sales Market Share in Volume by Application (2024-2033)
Table 54. Global IDH1 Antibody Sales by Application (2024-2033) & (US$ Million)
Table 55. Global IDH1 Antibody Sales Market Share in Value by Application (2024-2033)
Table 56. Global IDH1 Antibody Price by Application (2024-2033) & (US$/ml)
Table 57. North America IDH1 Antibody Sales by Application (2018-2023) (ml)
Table 58. North America IDH1 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe IDH1 Antibody Sales by Application (2018-2023) (ml)
Table 60. Europe IDH1 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific IDH1 Antibody Sales by Application (2018-2023) (ml)
Table 62. Asia-Pacific IDH1 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America IDH1 Antibody Sales by Application (2018-2023) (ml)
Table 64. Latin America IDH1 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa IDH1 Antibody Sales by Application (2018-2023) (ml)
Table 66. Middle East and Africa IDH1 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 67. North America IDH1 Antibody Sales by Country (2018-2023) & (ml)
Table 68. North America IDH1 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 69. North America IDH1 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 70. North America IDH1 Antibody Sales Market Share in Value by Country (2018-2023)
Table 71. North America IDH1 Antibody Sales by Country (2024-2033) & (ml)
Table 72. North America IDH1 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 73. North America IDH1 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 74. North America IDH1 Antibody Sales Market Share in Value by Country (2024-2033)
Table 75. Europe IDH1 Antibody Sales by Country (2018-2023) & (ml)
Table 76. Europe IDH1 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe IDH1 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe IDH1 Antibody Sales Market Share in Value by Country (2018-2023)
Table 79. Europe IDH1 Antibody Sales by Country (2024-2033) & (ml)
Table 80. Europe IDH1 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 81. Europe IDH1 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 82. Europe IDH1 Antibody Sales Market Share in Value by Country (2024-2033)
Table 83. Asia-Pacific IDH1 Antibody Sales by Region (2018-2023) & (ml)
Table 84. Asia-Pacific IDH1 Antibody Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific IDH1 Antibody Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific IDH1 Antibody Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific IDH1 Antibody Sales by Region (2024-2033) & (ml)
Table 88. Asia-Pacific IDH1 Antibody Sales Market Share in Volume by Region (2024-2033)
Table 89. Asia-Pacific IDH1 Antibody Sales by Region (2024-2033) & (US$ Million)
Table 90. Asia-Pacific IDH1 Antibody Sales Market Share in Value by Region (2024-2033)
Table 91. Latin America IDH1 Antibody Sales by Country (2018-2023) & (ml)
Table 92. Latin America IDH1 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America IDH1 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America IDH1 Antibody Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America IDH1 Antibody Sales by Country (2024-2033) & (ml)
Table 96. Latin America IDH1 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 97. Latin America IDH1 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 98. Latin America IDH1 Antibody Sales Market Share in Value by Country (2024-2033)
Table 99. Middle East and Africa IDH1 Antibody Sales by Country (2018-2023) & (ml)
Table 100. Middle East and Africa IDH1 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa IDH1 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa IDH1 Antibody Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa IDH1 Antibody Sales by Country (2024-2033) & (ml)
Table 104. Middle East and Africa IDH1 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 105. Middle East and Africa IDH1 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 106. Middle East and Africa IDH1 Antibody Sales Market Share in Value by Country (2024-2033)
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 110. Merck IDH1 Antibody Product
Table 111. Merck Recent Development
Table 112. GeneTex Company Information
Table 113. GeneTex Introduction and Business Overview
Table 114. GeneTex IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 115. GeneTex IDH1 Antibody Product
Table 116. GeneTex Recent Development
Table 117. Abcam Company Information
Table 118. Abcam Introduction and Business Overview
Table 119. Abcam IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 120. Abcam IDH1 Antibody Product
Table 121. Abcam Recent Development
Table 122. BosterBio Company Information
Table 123. BosterBio Introduction and Business Overview
Table 124. BosterBio IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 125. BosterBio IDH1 Antibody Product
Table 126. BosterBio Recent Development
Table 127. Proteintech Group Company Information
Table 128. Proteintech Group Introduction and Business Overview
Table 129. Proteintech Group IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 130. Proteintech Group IDH1 Antibody Product
Table 131. Proteintech Group Recent Development
Table 132. Abnova Corporation Company Information
Table 133. Abnova Corporation Introduction and Business Overview
Table 134. Abnova Corporation IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 135. Abnova Corporation IDH1 Antibody Product
Table 136. Abnova Corporation Recent Development
Table 137. Novus Biologicals Company Information
Table 138. Novus Biologicals Introduction and Business Overview
Table 139. Novus Biologicals IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 140. Novus Biologicals IDH1 Antibody Product
Table 141. Novus Biologicals Recent Development
Table 142. NSJ Bioreagents Company Information
Table 143. NSJ Bioreagents Introduction and Business Overview
Table 144. NSJ Bioreagents IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 145. NSJ Bioreagents IDH1 Antibody Product
Table 146. NSJ Bioreagents Recent Development
Table 147. LifeSpan BioSciences Company Information
Table 148. LifeSpan BioSciences Introduction and Business Overview
Table 149. LifeSpan BioSciences IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 150. LifeSpan BioSciences IDH1 Antibody Product
Table 151. LifeSpan BioSciences Recent Development
Table 152. Abeomics Company Information
Table 153. Abeomics Introduction and Business Overview
Table 154. Abeomics IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 155. Abeomics IDH1 Antibody Product
Table 156. Abeomics Recent Development
Table 157. ProSci Company Information
Table 158. ProSci Introduction and Business Overview
Table 159. ProSci IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 160. ProSci IDH1 Antibody Product
Table 161. ProSci Recent Development
Table 162. QED Bioscience Company Information
Table 163. QED Bioscience Introduction and Business Overview
Table 164. QED Bioscience IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 165. QED Bioscience IDH1 Antibody Product
Table 166. QED Bioscience Recent Development
Table 167. Cell Signaling Technology Company Information
Table 168. Cell Signaling Technology Introduction and Business Overview
Table 169. Cell Signaling Technology IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 170. Cell Signaling Technology IDH1 Antibody Product
Table 171. Cell Signaling Technology Recent Development
Table 172. RayBiotech Company Information
Table 173. RayBiotech Introduction and Business Overview
Table 174. RayBiotech IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 175. RayBiotech IDH1 Antibody Product
Table 176. RayBiotech Recent Development
Table 177. EpiGentek Company Information
Table 178. EpiGentek Introduction and Business Overview
Table 179. EpiGentek IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 180. EpiGentek IDH1 Antibody Product
Table 181. EpiGentek Recent Development
Table 182. Enzo Life Sciences Company Information
Table 183. Enzo Life Sciences Introduction and Business Overview
Table 184. Enzo Life Sciences IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 185. Enzo Life Sciences IDH1 Antibody Product
Table 186. Enzo Life Sciences Recent Development
Table 187. OriGene Technologies Company Information
Table 188. OriGene Technologies Introduction and Business Overview
Table 189. OriGene Technologies IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 190. OriGene Technologies IDH1 Antibody Product
Table 191. OriGene Technologies Recent Development
Table 192. Jingjie PTM BioLab Company Information
Table 193. Jingjie PTM BioLab Introduction and Business Overview
Table 194. Jingjie PTM BioLab IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 195. Jingjie PTM BioLab IDH1 Antibody Product
Table 196. Jingjie PTM BioLab Recent Development
Table 197. Beijing Solarbio Company Information
Table 198. Beijing Solarbio Introduction and Business Overview
Table 199. Beijing Solarbio IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 200. Beijing Solarbio IDH1 Antibody Product
Table 201. Beijing Solarbio Recent Development
Table 202. Biobyt Company Information
Table 203. Biobyt Introduction and Business Overview
Table 204. Biobyt IDH1 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 205. Biobyt IDH1 Antibody Product
Table 206. Biobyt Recent Development
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. IDH1 Antibody Market Trends
Table 210. IDH1 Antibody Market Drivers
Table 211. IDH1 Antibody Market Challenges
Table 212. IDH1 Antibody Market Restraints
Table 213. IDH1 Antibody Distributors List
Table 214. IDH1 Antibody Downstream Customers
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. IDH1 Antibody Product Picture
Figure 2. Global IDH1 Antibody Market Size, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global IDH1 Antibody Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global IDH1 Antibody Sales Status and Outlook (2018-2033) & (ml)
Figure 5. Product Picture of Monoclonal
Figure 6. Global Monoclonal Sales YoY Growth (2018-2033) & (ml)
Figure 7. Product Picture of Polyclonal
Figure 8. Global Polyclonal Sales YoY Growth (2018-2033) & (ml)
Figure 9. Global IDH1 Antibody Sales by Type (2018-2033) & (US$ Million)
Figure 10. Global IDH1 Antibody Sales Market Share by Type in 2022 & 2033
Figure 11. North America IDH1 Antibody Sales Market Share in Volume by Type in 2022
Figure 12. North America IDH1 Antibody Sales Market Share in Value by Type in 2022
Figure 13. Europe IDH1 Antibody Sales Market Share in Volume by Type in 2022
Figure 14. Europe IDH1 Antibody Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific IDH1 Antibody Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific IDH1 Antibody Sales Market Share in Value by Type in 2022
Figure 17. Latin America IDH1 Antibody Sales Market Share in Volume by Type in 2022
Figure 18. Latin America IDH1 Antibody Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa IDH1 Antibody Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa IDH1 Antibody Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by IDH1 Antibody Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by IDH1 Antibody Revenue in 2022
Figure 23. IDH1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Immunochemistry (IHC)
Figure 25. Global Immunochemistry (IHC) Sales YoY Growth (2018-2033) & (ml)
Figure 26. Product Picture of Immunofluorescence (IF)
Figure 27. Global Immunofluorescence (IF) Sales YoY Growth (2018-2033) & (ml)
Figure 28. Product Picture of Immunoprecipitation (IP)
Figure 29. Global Immunoprecipitation (IP) Sales YoY Growth (2018-2033) & (ml)
Figure 30. Product Picture of Western Blot (WB)
Figure 31. Global Western Blot (WB) Sales YoY Growth (2018-2033) & (ml)
Figure 32. Product Picture of ELISA
Figure 33. Global ELISA Sales YoY Growth (2018-2033) & (ml)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2033) & (ml)
Figure 36. Global IDH1 Antibody Sales by Application (2018-2033) & (US$ Million)
Figure 37. Global IDH1 Antibody Sales Market Share by Application in 2022 & 2033
Figure 38. North America IDH1 Antibody Sales Market Share in Volume by Application in 2022
Figure 39. North America IDH1 Antibody Sales Market Share in Value by Application in 2022
Figure 40. Europe IDH1 Antibody Sales Market Share in Volume by Application in 2022
Figure 41. Europe IDH1 Antibody Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific IDH1 Antibody Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific IDH1 Antibody Sales Market Share in Value by Application in 2022
Figure 44. Latin America IDH1 Antibody Sales Market Share in Volume by Application in 2022
Figure 45. Latin America IDH1 Antibody Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa IDH1 Antibody Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. IDH1 Antibody Manufacturing Cost Structure
Figure 49. IDH1 Antibody Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed